Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib in Prostate Cancer with Rising PSA
NCT00136487Phase 3Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Oct 2002
- Primary completion
- Sep 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of celecoxib in prostate cancer (PCa), sponsored by Dana-Farber Cancer Institute. Started Oct 2002; status: completed.
02
Drugs
celecoxib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00136487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00136487.